Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study.

BACKGROUND Cell transplantation for the regeneration of ischemic myocardium is limited by poor graft viability and low cell retention. In ischemic cardiomyopathy, the extracellular matrix is deeply altered; therefore, it could be important to associate a procedure aiming at regenerating myocardial cells and restoring the extracellular matrix function. We evaluated the feasibility and safety of intrainfarct cell therapy associated with a cell-seeded collagen scaffold grafted onto infarcted ventricles. METHODS In 20 consecutive patients presenting with left ventricular postischemic myocardial scars and indication for coronary artery bypass graft surgery, bone marrow cells were implanted during surgery. In the last 10 patients, we added a collagen matrix seeded with bone marrow cells, placed onto the scar. RESULTS There was no mortality and any related adverse events (follow-up 10 +/- 3.5 months). New York Heart Association functional class improved in both groups from 2.3 +/- 0.5 to 1.3 +/- 0.5 (matrix, p = 0.0002) versus 2.4 +/- 0.5 to 1.5 +/- 0.5 (no matrix, p = 0.001). Left ventricular end-diastolic volume evolved from 142.4 +/- 24.5 mL to 112.9 +/- 27.3 mL (matrix, p = 0.02) versus 138.9 +/- 36.1 mL to 148.7 +/- 41 mL (no matrix, p = 0.57), left ventricular filling deceleration time improved significantly in the matrix group from 162 +/- 7 ms to 198 +/- 9 ms (p = 0.01) versus the no-matrix group (from 159 +/- 5 ms to 167 +/- 8 ms, p = 0.07). Scar area thickness progressed from 6 +/- 1.4 to 9 mm +/- 1.1 mm (matrix, p = 0.005) versus 5 +/- 1.5 mm to 6 +/- 0.8 mm (no matrix, p = 0.09). Ejection fraction improved in both groups, from 25.3% +/- 7.3% to 32% +/- 5.4% (matrix, p = 0.03) versus 27.2% +/- 6.9% to 34.6% +/- 7.3% (no matrix, p = 0.031). CONCLUSIONS This tissue-engineered approach is feasible and safe and appears to improve the efficiency of cellular cardiomyoplasty. The cell-seeded collagen matrix increases the thickness of the infarct scar with viable tissue and helps to normalize cardiac wall stress in injured regions, thus limiting ventricular remodeling and improving diastolic function.

[1]  F. Prósper,et al.  Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. , 2004, International journal of cardiology.

[2]  S. Dymarkowski,et al.  Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial , 2006, The Lancet.

[3]  B. Strauss,et al.  Cell transplantation preserves matrix homeostasis: a novel paracrine mechanism. , 2005, The Journal of thoracic and cardiovascular surgery.

[4]  E. Taraldsrud,et al.  Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[5]  M. D. de Bruijn,et al.  From hemangioblast to hematopoietic stem cell: an endothelial connection? , 2005, Experimental hematology.

[6]  S. Mittnacht,et al.  Heterogeneous proliferative potential in regenerative adult newt cardiomyocytes , 2003, Journal of Cell Science.

[7]  D. Torella,et al.  Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Couffinhal,et al.  Repair of myocardial infarction by epicardial deposition of bone-marrow-cell-coated muscle patch in a murine model. , 2004, The Annals of thoracic surgery.

[9]  A. Carpentier,et al.  Cellular Cardiomyoplasty for Myocardial Regeneration , 2005, Asian cardiovascular & thoracic annals.

[10]  G. Chatellier,et al.  Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study. , 2004, The Journal of thoracic and cardiovascular surgery.

[11]  M. Vannan,et al.  Ventricular remodelling after myocardial infarction , 1992, British heart journal.

[12]  Mitchel S Berger,et al.  Neural stem cells and the origin of gliomas. , 2005, The New England journal of medicine.

[13]  K. Reynen,et al.  Intracoronary radiotherapy with a 188rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up , 2004 .

[14]  P. Schirmacher,et al.  Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end‐stage dilated, ischaemic and valvular cardiomyopathy , 2006, Histopathology.

[15]  A. Carpentier,et al.  Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. , 2007, Tissue engineering.

[16]  M. Keating,et al.  Heart Regeneration in Zebrafish , 2002, Science.

[17]  D. Shum-Tim,et al.  Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. , 2006, The Journal of thoracic and cardiovascular surgery.

[18]  Giulio Cossu,et al.  Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart , 2004, Circulation research.

[19]  Gustav Steinhoff,et al.  Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. , 2007, The Journal of thoracic and cardiovascular surgery.

[20]  B. Nadal-Ginard,et al.  Bone marrow cells have a potent anti-ischemic effect against myocardial cell death in humans. , 2006, The Journal of thoracic and cardiovascular surgery.

[21]  F. Prósper,et al.  Cellular cardiomyoplasty: clinical application. , 2004, The Annals of thoracic surgery.

[22]  A. Berrebi,et al.  Cellular therapy reverses myocardial dysfunction. , 2001, The Journal of thoracic and cardiovascular surgery.

[23]  D. Ponzin,et al.  p63 identifies keratinocyte stem cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Gnecchi,et al.  Enhancing stem cell therapy through genetic modification. , 2005, Journal of the American College of Cardiology.

[25]  A. Zeiher,et al.  Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.

[26]  Ahmad Y. Sheikh,et al.  Collagen Matrices Enhance Survival of Transplanted Cardiomyoblasts and Contribute to Functional Improvement of Ischemic Rat Hearts , 2006, Circulation.

[27]  C. Murry,et al.  Regenerating the heart , 2005, Nature Biotechnology.

[28]  A. Ganser,et al.  Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction: Eighteen Months’ Follow-Up Data From the Randomized, Controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) Trial , 2006, Circulation.

[29]  Michael D. Schneider,et al.  Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  X. Qin,et al.  Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. , 2005, The Annals of thoracic surgery.

[31]  L. Brown.  Cardiac extracellular matrix: a dynamic entity. , 2005, American journal of physiology. Heart and circulatory physiology.

[32]  Rutger-Jan Swijnenburg,et al.  Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[33]  Andreas Hess,et al.  Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts , 2006, Nature Medicine.

[34]  Randall J Lee,et al.  Biomaterials for the treatment of myocardial infarction. , 2006, Journal of the American College of Cardiology.

[35]  J. Kresh.  Cell replacement therapy: the functional importance of myocardial architecture and intercellular gap-junction distribution. , 2006, The Journal of thoracic and cardiovascular surgery.

[36]  A. Zeiher,et al.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[37]  Ying Zhang,et al.  Cellular Cardiomyoplasty: Improvement of Left Ventricular Function Correlates with the Release of Cardioactive Cytokines , 2007, Stem cells.

[38]  Thomas Eschenhagen,et al.  Engineering Myocardial Tissue , 2005, Circulation research.

[39]  M. Rudnicki,et al.  The post‐natal heart contains a myocardial stem cell population , 2002, FEBS letters.

[40]  松浦 勝久.  Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes , 2006 .

[41]  Peter Niederer,et al.  The myocardium and its fibrous matrix working in concert as a spatially netted mesh: a critical review of the purported tertiary structure of the ventricular mass. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[42]  Smadar Cohen,et al.  Renovation of the injured heart with myocardial tissue engineering , 2006, Expert review of cardiovascular therapy.

[43]  Clotilde Castaldo,et al.  Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[45]  P. Poole‐Wilson,et al.  The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. , 2005, Journal of the American College of Cardiology.

[46]  Marie-Noëlle Giraud,et al.  Current state of the art in myocardial tissue engineering. , 2007, Tissue engineering.

[47]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[48]  M. Cho,et al.  Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. , 2007, Biomaterials.